RU2440117C1 - Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей - Google Patents

Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей Download PDF

Info

Publication number
RU2440117C1
RU2440117C1 RU2010117649/15A RU2010117649A RU2440117C1 RU 2440117 C1 RU2440117 C1 RU 2440117C1 RU 2010117649/15 A RU2010117649/15 A RU 2010117649/15A RU 2010117649 A RU2010117649 A RU 2010117649A RU 2440117 C1 RU2440117 C1 RU 2440117C1
Authority
RU
Russia
Prior art keywords
skin
patent literature
therapeutic agent
active ingredient
formula
Prior art date
Application number
RU2010117649/15A
Other languages
English (en)
Russian (ru)
Inventor
Синдзи ОНА (JP)
Синдзи ОНА
Коитиро ТАКЕСИТА (JP)
Коитиро ТАКЕСИТА
Наоки АНДО (JP)
Наоки АНДО
Масахиро ЯМАСИТА (JP)
Масахиро ЯМАСИТА
Original Assignee
Торэй Индастриз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Торэй Индастриз, Инк. filed Critical Торэй Индастриз, Инк.
Application granted granted Critical
Publication of RU2440117C1 publication Critical patent/RU2440117C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
RU2010117649/15A 2007-10-05 2008-10-03 Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей RU2440117C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007262015 2007-10-05
JP2007-262015 2007-10-05

Publications (1)

Publication Number Publication Date
RU2440117C1 true RU2440117C1 (ru) 2012-01-20

Family

ID=40526303

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010117649/15A RU2440117C1 (ru) 2007-10-05 2008-10-03 Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей

Country Status (14)

Country Link
US (1) US20100222309A1 (ja)
EP (1) EP2196206B8 (ja)
JP (1) JP5613417B2 (ja)
KR (1) KR101173509B1 (ja)
CN (1) CN101848714B (ja)
AU (1) AU2008308005B2 (ja)
BR (1) BRPI0817804A8 (ja)
CA (1) CA2702032C (ja)
ES (1) ES2748274T3 (ja)
MX (1) MX2010003660A (ja)
PL (1) PL2196206T3 (ja)
RU (1) RU2440117C1 (ja)
TW (1) TWI453020B (ja)
WO (1) WO2009044883A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX362830B (es) * 2010-01-29 2019-02-14 Toray Industries Agente terapeutico o profilactico para enfermedades del tracto biliar.
JP6013345B2 (ja) * 2010-10-19 2016-10-25 メモリアル スローン−ケタリング キャンサー センター 痛み治療用の４，５ａ−エポキシモルフィナンの６−アミド誘導体
CN103327977B (zh) 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂
EP2931725B1 (en) 2012-12-14 2017-02-15 Purdue Pharma LP Nitrogen containing morphinan derivatives and the use thereof
TW201441199A (zh) 2012-12-28 2014-11-01 Purdue Pharma Lp 經取代之嗎啡喃類及其用途
EP4212532A3 (en) 2015-04-30 2023-09-27 Memorial Sloan Kettering Cancer Center Mitragynine analogs and uses thereof
CN105461727A (zh) * 2015-12-01 2016-04-06 吕涛 一种纳呋拉啡的精制方法
WO2018160500A1 (en) 2017-03-03 2018-09-07 Ring Inc. Solar-charging mounting bracket for audio/video recording and communication devices
EP3761982B1 (en) 2018-03-08 2024-10-09 Victoria Link Ltd Use of nalfurafine for the treatment of demyelinating diseases
TW202216145A (zh) * 2020-06-30 2022-05-01 日商東麗股份有限公司 伴隨代謝異常之疾病或症候群中的肌力低下症狀之改善劑或預防劑
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc History of urea which can be used to treat cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
JP2521853B2 (ja) 1990-07-25 1996-08-07 タカラベルモント株式会社 化粧料
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
DE69414085T2 (de) 1993-07-19 1999-03-18 Toray Industries, Inc., Tokio/Tokyo Wirkstoff zum schutze von gehirnzellen
WO1995003308A1 (en) * 1993-07-23 1995-02-02 Toray Industries, Inc. Morphinan derivative and medicinal use
JPH07187990A (ja) 1993-12-24 1995-07-25 Toshiko Yamamoto 化粧料
ES2236630T3 (es) * 1996-11-25 2005-07-16 Toray Industries, Inc. Agente antipruritico.
US5834480A (en) 1997-06-13 1998-11-10 Elkhoury; George F. Topical application of opioids for treatment of acne and sebaceous gland disorders
AU6117298A (en) * 1997-07-25 1999-02-16 Toray Industries, Inc. Hyponatremia remedies
CA2270955C (en) 1997-09-02 2007-08-07 Toray Industries Inc. Pharmaceutical composition containing morphinan derivative for treating drug dependence
JP2000053572A (ja) 1998-08-11 2000-02-22 Toray Ind Inc ＯＲＬ１（ｏｐｉｏｉｄ ｏｒｐｈａｎ）受容体拮抗薬
CN1204139C (zh) 1999-08-24 2005-06-01 东丽株式会社 神经性疼痛治疗剂
CN100398154C (zh) 2001-03-30 2008-07-02 东丽株式会社 精神神经疾病治疗药
CA2451133C (en) 2001-05-08 2012-09-18 Toray Industries, Inc. Therapeutic agent for sepsis
JP2004107209A (ja) 2002-09-13 2004-04-08 Nippon Oruganon Kk 掻痒治療薬
JP4499034B2 (ja) * 2003-02-19 2010-07-07 久光製薬株式会社 Ｎ−アリール又はｎ−ヘテロアリールピペラジン誘導体及びそれを含有する医薬
JP2004352714A (ja) 2003-05-08 2004-12-16 Kyorin Pharmaceut Co Ltd 新規な４−（２−フロイル）アミノピペリジン誘導体
JP4381157B2 (ja) * 2004-02-03 2009-12-09 久光製薬株式会社 ２，２−ジフェニル−１−エタノン誘導体及びそれを含有する医薬
ES2423004T3 (es) * 2005-03-10 2013-09-17 Toray Industries, Inc. Agente antiprurítico para el prurito provocado por la esclerosis múltiple
WO2007053194A2 (en) * 2005-06-03 2007-05-10 The University Of Chicago Modulation of cell barrier dysfunction

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ПОКРОВСКИЙ В.И. Энциклопедический словарь медицинских терминов. 2-е изд. - М.: Медицина, 2001, с.878. *
Пронина Н.А. Иммуно-морфологические механизмы формирования и течения атопического дерматита //. Дисс. на соиск. учен. ст. канд. мед. наук. - Томск, 2004, с.21. *

Also Published As

Publication number Publication date
CN101848714A (zh) 2010-09-29
PL2196206T3 (pl) 2020-02-28
ES2748274T3 (es) 2020-03-16
AU2008308005B2 (en) 2012-06-07
EP2196206B1 (en) 2019-07-17
CA2702032A1 (en) 2009-04-09
TWI453020B (zh) 2014-09-21
MX2010003660A (es) 2010-08-10
CA2702032C (en) 2013-04-02
EP2196206B8 (en) 2019-11-13
EP2196206A4 (en) 2010-09-22
WO2009044883A1 (ja) 2009-04-09
CN101848714B (zh) 2014-08-20
US20100222309A1 (en) 2010-09-02
EP2196206A1 (en) 2010-06-16
KR101173509B1 (ko) 2012-08-14
BRPI0817804A2 (pt) 2016-10-11
AU2008308005A1 (en) 2009-04-09
JPWO2009044883A1 (ja) 2011-02-10
TW200927116A (en) 2009-07-01
BRPI0817804A8 (pt) 2017-04-18
KR20100049683A (ko) 2010-05-12
JP5613417B2 (ja) 2014-10-22

Similar Documents

Publication Publication Date Title
RU2440117C1 (ru) Терапевтическое средство для улучшения свойств кожи, включающее в качестве действующего ингредиента производное морфинана или любую из его фармакологически приемлемых кислотно-аддитивных солей
KR100557801B1 (ko) 소양증치료제
JP2004509920A (ja) カテコールアミン医薬組成物および方法
KR101338681B1 (ko) 밤껍질 추출물을 포함하는 건강 식품 또는 약학 조성물
EP3182955B1 (en) Compositions and methods for controlled moisturizing and release of active ingredients
JP2003518066A (ja) オリゴ糖を含む組成物、特に化粧品用または皮膚科用組成物、その調製方法、および化粧品処置方法
AU2010248292A1 (en) Composition for preventing hair loss or for stimulating hair growth
CN116731111A (zh) 合成肽及其组合物和用途
WO2010019450A2 (en) Synergizing active compounds for treating inflammation and other conditions
AU8952282A (en) Method of treating pruritis and composition therefor
US20150352100A1 (en) Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands
JPH10175868A (ja) 津液改善組成物
EP3269349B1 (en) Use of a topically applied cosmetic composition containing keratin and sulphur
JP7396585B2 (ja) Ｔｓｌｐ遺伝子発現抑制用、ｉｌ－３３遺伝子発現抑制用、又はフィラグリン産生促進用組成物
KR20240019215A (ko) 개선된 세포 투과성 핵 수송 억제제를 포함하는 피부 보습 및 피부 진정용 화장료 조성물
KR100789344B1 (ko) 올리고뉴클레오타이드를 포함하는 피부 노화 방지제
EP0988039B1 (en) Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation
KR20040065864A (ko) 피부알러지 완화 및 예방용 조성물
US20060088556A1 (en) Topical formulation and use of buspirone
CZ2014416A3 (cs) Využití substituovaných analogů alaptidu jako modifikátorů transdermální penetrace ve farmaceutických kompozicích pro humánní a veterinární aplikace
KR20160064404A (ko) 파낙시돌을 함유하는 보습용 조성물